Physician profile
Christopher C Robinson
NPI 1427266584
$4,642.97
in general payments reported to CMS, 2019-2025
13 companies · $902 in 2025
The $902 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.17 · 2022: $285 · 2023: $455 · 2024: $2,978 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,120 · Travel and Lodging: $180 · Education: $35.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,120.06 |
| Travel and Lodging | $179.67 |
| Education | $35.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,371.32 | 2022-2025 | Wavewriter Alpha Prime 16, Avista Mri |
| Stratus Medical, LLC | $931.62 | 2023-2025 | Nimbus |
| Biotronik Nro, INC. | $591.60 | 2024-2025 | Prospera |
| Alcon Vision LLC | $512.88 | 2021-2025 | Clareon, Centurion |
| Abbott Laboratories | $313.76 | 2024 | Eterna, Proclaim |
| Abbvie INC. | $290.34 | 2022-2025 | |
| Lundbeck LLC | $248.65 | 2024 | Vyepti |
| Intuitive Surgical, INC. | $179.67 | 2024 | |
| Medtronic, INC. | $80.98 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Sun Pharmaceutical Industries INC. | $42.50 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.52 | 2023 | |
| Bausch & Lomb Americas INC. | $24.62 | 2023 | Miebo |
| Alimera Sciences, INC. | $22.51 | 2023 | Iluvien |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.